ÂÜÀòÂÒÂ×

Mr. Blair was named the Chief Commercial Officer for Verax Biomedical in 2019. He came to Verax from Fresenius Kabi which operated as Verax’s commercial partner from 2009 to 2019. Through-out his career Mr. Blair has focused on guiding businesses through transformation. He consulted on the spin-off of the Fenwal division from Baxter Healthcare in 2007, and once it was operationally independent, worked to re-position Fenwal for its acquisition by Fresenius Kabi in 2012. Mr. Blair held a variety of executive positions at Cardinal Health, Allegiance and Baxter Healthcare. He created and led the Integrated Supply Solution division at Cardinal Health as its VP/GM until 2007. Mr. Blair worked on the spin-off of Allegiance from Baxter Healthcare in 1996 and supported the repositioning of Allegiance for acquisition by Cardinal Health in 1999. He has held leadership roles in many functional areas including strategy, marketing, sales, finance and operations. Mr. Blair received his B.S. in Quantitative Business Analysis from Indiana University Kelley School of Business.